BioAffinity Technologies Reports Fourth Quarter and Full Year 2022 Financial Results
Conference Call Scheduled for April 3, 2023, at 9:00 a.m. Eastern Time ... | March 31, 2023
Stay updated with breaking news from Bioaffinity Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Conference Call Scheduled for April 3, 2023, at 9:00 a.m. Eastern Time ... | March 31, 2023
BioAffinity Technologies, Inc. today announced the publication of a paper titled “Porphyrin-modified beads for use as compensation controls in flow cytometry” in the peer-reviewed... | March 28, 2023
Conference Call scheduled on April 3, 2023, at 9 a.m. Eastern time ... | March 24, 2023
BioAffinity focuses on the development of noninvasive, early-stage cancer diagnosis and targeted cancer treatment.
BioAffinity Technologies, Inc. , a biotechnology company addressing the need for noninvasive diagnosis of early-stage cancer and diseases of the lung, as well as targeted cancer treatment, today... | December 15, 2022